Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
02.06.25
/
50%
€3.07
Target price
02.06.26
€13.19
Performance (%)
-95.13%
Price
27.03.26
€0.17
Summary
This prediction is currently active. Massive losses of -95.13% have been the result for the BUY prediction by Oppenheimer_Holdings. This prediction currently runs until 02.06.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -16.850% | -16.850% |
| iShares Core DAX® | -0,48 % | -12,06 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % |
| iShares S&P 500 | -2,27 % | -5,05 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.52
11.09.25
11.09.25
€28.21
11.09.26
11.09.26
-98.89%
27.03.26
27.03.26
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.39
19.08.24
19.08.24
€13.55
19.08.25
19.08.25
28.32%
20.08.25
20.08.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.29
01.04.24
01.04.24
€13.96
01.04.25
01.04.25
-32.11%
02.04.25
02.04.25